Lin Shu-Bo, Zheng Ze-Xuan, Zhang Rui
Shantou Blood Center, Shantou 515064, Guangdong Province, China,E-mail:
Shantou Blood Center, Shantou 515064, Guangdong Province, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019 Apr;27(2):569-572. doi: 10.19746/j.cnki.issn.1009-2137.2019.02.042.
To explore the application of blood screening method based on chemiluminescence immunoassay(CLIA)and to evaluate its officacy.
Screening HBsAg, anti-HCV, anti-HIV and TP was performed on 3,530 voluntary blood donors by ELISA and CLIA, and then all the specimens with ELISA and ELISA/CLIA were further confirmed by NAT; TP single and double positive specimens by ELISA or CLIA were further confirmed by TPPA.
The results of CLIA method was well consistent with NAT results, displaying better repeatability and higher sensitivity than ELISA method. For CLIA/ELISA specimens there was a certain false-negative result obtained by ELISA method, especially for blood donors with low virus biter concentration or "window period".
ELISA and CLIA have complementary advantages in blood screening, which can improve the sensitivity of blood screening, reduce the missed detection and shorten detection time. The introduction of CLIA for blood screening is of great importance for ensuring the quality of blood and the safety of clinical transfusion.
探讨基于化学发光免疫分析(CLIA)的血液筛查方法的应用并评估其效果。
采用酶联免疫吸附测定(ELISA)和CLIA对3530名无偿献血者进行乙肝表面抗原(HBsAg)、丙型肝炎病毒抗体(抗-HCV)、艾滋病病毒抗体(抗-HIV)及梅毒螺旋体抗体(TP)筛查,然后将所有ELISA及ELISA/CLIA检测的标本采用核酸扩增技术(NAT)进一步确证;ELISA或CLIA检测TP单阳性和双阳性标本采用梅毒螺旋体颗粒凝集试验(TPPA)进一步确证。
CLIA法检测结果与NAT结果一致性良好,重复性和灵敏度均优于ELISA法。对于CLIA/ELISA标本,ELISA法存在一定的假阴性结果,尤其是病毒载量低的献血者或处于“窗口期”的献血者。
ELISA和CLIA在血液筛查中具有互补优势,可提高血液筛查的灵敏度,减少漏检,缩短检测时间。引入CLIA进行血液筛查对保证血液质量和临床输血安全具有重要意义。